| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.55 | 0.05 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.29 | 0.3 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.2 | 0.02 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.16 | 0.04 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.04 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.09 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.09 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.2 |